José Luis Tisaire

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

Josep Tabernero, José A. Martinez‐Climent, Aňa Lluch et al. · Annals of Oncology · 2004 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Phase II study of radiochemotherapy with uft and low-dose oral leucovorin in patients with unresectable rectal cancer

Alejandro de la Torre, Salvador Boccaletti Ramos, Francisco Valcárcel et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 62 citations

Medicine, Oncology, Pharmacology +10

Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

Xavier García del Muro, E. Marcuello, Josep Gumà et al. · British Journal of Cancer · 2002 · 53 citations · Full text

Medicine, Oncology, Pharmacology +13

Cost-minimisation analysis of three regimens of chemotherapy (docetaxel–cisplatin, paclitaxel–cisplatin, paclitaxel–carboplatin) for advanced non-small-cell lung cancer

Carlos Rubio-Terrés, José Luis Tisaire, Svetlana Kobina et al. · Lung Cancer · 2002 · 26 citations

Medicine, Oncology, Pharmacoeconomics +10

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study

Emilio Fonseca, Juan J. Grau, Javier Sastre et al. · European Journal of Cancer · 2005 · 23 citations

Medicine, Oncology, Pharmacology +8